Showing results (231-240 of 302) with videos related to

Sort By:
Pageof 31
Nature|September 1, 2015
η-Secretase processing of APP inhibits neuronal activity in the hippocampusMichael Willem, Sabina Tahirovic, Marc Aurel Busche, et al.
Alzheimer'S Research & Therapy|January 19, 2019
Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samplesSteffen Wolfsgruber, José Luis Molinuevo, Michael Wagner, et al.
EMBO Molecular Medicine|March 5, 2016
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markersMarc Suárez-Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2025
SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studiesElizabeth Kuhn, Hannah M Klinger, Rebecca E Amariglio, et al.
Neurology|July 9, 2020
Minor neuropsychological deficits in patients with subjective cognitive declineSteffen Wolfsgruber, Luca Kleineidam, Jannis Guski, et al.
Frontiers in Aging Neuroscience|May 10, 2021
Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive DeclineNiels Hansen, Aditya Singh, Claudia Bartels, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2024
Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired IndividualsLena Sannemann, Claudia Bartels, Frederic Brosseron, et al.
Journal of Neurology|December 24, 2025
CSF biomarkers of neuroinflammation are associated with regional atrophySerap Özlü, Martin Dyrba, Alice Grazia, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 12, 2024
Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive declineStefan J Teipel, Martin Dyrba, Luca Kleineidam, et al.
Pageof 31